Furthermore, as C2orf27A functions as a competitive endogenous RNA by sequestering miR-610, which subsequently leads to the upregulation of NOX4, targeted interventions aimed at inhibiting C2orf27A represent a novel therapeutic strategy that holds the potential to disrupt this oncogenic pathway, offering a novel treatment option for GC. Here, NOX4 is linked to gastric cancer.